Replies to post #242757 on Biotech Values

[swampboots]

What think you: DTIL $2?

With eyes on first allogeneic CAR-T approval, Precision touts 100% response in 'small niche' population – Endpoints News (endpts.com)

https://endpts.com/with-eyes-on-first-allogeneic-car-t-approval-precision-touts-100-response-in-small-niche-population/?utm_medium=email&utm_campaign=1486%20-%20As%20Moderna%20touts%20Omicron%20booster%20top%20analyst%20says%20MA%20will%20soon%20be%20needed%20Bristol%20Myers%20ups%20the%20ante%20in%20AI%20with%20new%20biotech%20partnership%20Basic&utm_content=1486%20-%20As%20Moderna%20touts%20Omicron%20booster%20top%20analyst%20says%20MA%20will%20soon%20be%20needed%20Bristol%20Myers%20ups%20the%20ante%20in%20AI%20with%20new%20biotech%20partnership%20Basic+CID_6945d38e34406c0918c370e2a5f5ce01&utm_source=ENDPOINTS%20emails&utm_term=With%20eyes%20on%20first%20allogeneic%20CAR-T%20approval%20Precision%20touts%20100%20response%20in%20small%20niche%20population

[DewDiligence]

RIGL withdraws fostamatinib sNDA—reduces workforce:

https://finance.yahoo.com/news/rigel-provides-plans-snda-waiha-204500299.html